A retrospective study conducted at the University Health Network found that, in liver transplant recipients with diabetes, combination therapy reduced HbA1c and alanine aminotransferase levels more effectively than DPP-4 inhibitors. Additionally, two clinical trials in patients with Type 2 diabetes demonstrated that combination therapy significantly lowered HbA1c by 1.34% and 1.21%, compared to a 0.54% reduction with placebo, starting from a baseline of 8.0%. These findings suggest that combination therapy may be especially beneficial in the liver transplant population, where patients often experience weight gain and develop metabolic co-morbidities
AC metabolism) in conjunction with the expression of specific clinical symptoms (e.g
While we are still learning more about the relationship between diet and GLP-1 production, most of these principles result in a healthier diet overall regardless of GLP-1 production
Head or whiplash injuries - brain injuries are associated with delayed gastrointestinal emptying due to changes in the autonomic nervous system
Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study
Vitamin Shots Quick injections for an extra boost